And, they further verified that the DHEA-converted active estrogens exert its anti-NAFLD effect through precisely activating G protein-coupled estrogen receptor (GPER1, also called GRP30) rather than the nuclear estrogen receptors in liver [14]. The gene discussed is GPER1; the disease is metabolic dysfunction-associated steatotic liver disease.